Esperion Therapeutics, Inc. (ESPR) Ownership

$0.85

$0.02 (-2.39%)
Last update: 04:00 PM EST
Day's range
$0.81
Day's range
$0.87

Esperion Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 14.49 M $20.87 M   1.81% 7.39%
VANGUARD GROUP INC 05/09/2025 11.49 M $16.54 M   -1.95% 5.86%
WASATCH ADVISORS LP 05/15/2025 10.93 M $15.74 M   -55.35% 5.57%
BELLEVUE GROUP AG 05/14/2025 9.69 M $13.96 M   -2.51% 4.94%
TWO SEAS CAPITAL LP 05/15/2025 6.93 M $9.98 M   11.23% 3.53%
MORGAN STANLEY 05/15/2025 6.59 M $9.48 M   4.39% 3.36%
STATE STREET CORP 05/15/2025 4.55 M $6.55 M   0.98% 2.32%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 4.45 M $6.40 M   2.45% 2.27%
MARSHALL WACE, LLP 05/15/2025 3.63 M $5.23 M   100.00% 1.85%
05/12/2025 3.09 M $4.45 M   100.00% 1.57%
INDABA CAPITAL MANAGEMENT, L.P. 05/15/2025 3.00 M $4.32 M   0.00% 1.53%
TWO SIGMA INVESTMENTS, LP 05/15/2025 2.73 M $3.93 M   -22.85% 1.39%
TWO SIGMA ADVISERS, LP 05/15/2025 2.53 M $3.64 M   -30.12% 1.29%
CITADEL ADVISORS LLC 05/15/2025 2.09 M $3.01 M   19.18% 1.07%
PENDERFUND CAPITAL MANAGEMENT LTD. 05/15/2025 2.00 M $4.14 M   100.00% 1.02%
JPMORGAN CHASE & CO 05/12/2025 1.92 M $2.77 M   -21.70% 0.98%
NORTHERN TRUST CORP 05/13/2025 1.54 M $2.22 M   -0.07% 0.78%
GOLDMAN SACHS GROUP INC 05/16/2025 1.53 M $2.20 M   -44.53% 0.78%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.53 M $2.20 M   -6.30% 0.78%
WOODLINE PARTNERS LP 05/15/2025 1.50 M $2.17 M   0.00% 0.77%
WELLS FARGO & COMPANY/MN 05/13/2025 1.22 M $1.75 M   1,023.18% 0.62%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 05/14/2025 1.07 M $1.54 M   -44.31% 0.54%
MILLENNIUM MANAGEMENT LLC 05/15/2025 961.04 K $1.38 M   15.80% 0.49%
SQUAREPOINT OPS LLC 05/15/2025 877.41 K $1.26 M   158.80% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/12/2025 822.62 K $1.18 M   -11.74% 0.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 762.63 K $1.10 M   4.72% 0.39%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 761.98 K $1.10 M   36.00% 0.39%
HRT FINANCIAL LP 05/15/2025 669.83 K $964.00 K   19.50% 0.34%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 554.22 K $798.07 K   0.00% 0.28%
GRAHAM CAPITAL MANAGEMENT, L.P. 05/15/2025 487.74 K $702.34 K   153.48% 0.25%
DIAMETRIC CAPITAL, LP 05/14/2025 430.18 K $619.45 K   21.52% 0.22%
BANK OF NEW YORK MELLON CORP 04/29/2025 415.14 K $597.80 K   -2.90% 0.21%
CITADEL ADVISORS LLC 05/15/2025 396.40 K $570.82 K   -35.68% 0.20%
SUMMIT WEALTH GROUP, LLC 05/02/2025 293.00 K $422.00 K   86.62% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 282.10 K $406.22 K   -41.68% 0.14%
D. E. SHAW & CO., INC. 05/15/2025 275.71 K $397.02 K   9.59% 0.14%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 271.61 K $391.12 K   77.28% 0.14%
INVESCO LTD. 05/12/2025 255.48 K $367.89 K   161.14% 0.13%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 05/12/2025 254.27 K $366.14 K   0.00% 0.13%
BARCLAYS PLC 05/15/2025 236.13 K $340.00 K   -34.27% 0.12%
RHUMBLINE ADVISERS 05/29/2025 236.03 K $339.87 K   -4.41% 0.12%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 05/15/2025 222.48 K $320.37 K   0.00% 0.11%
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN 05/09/2025 195.13 K $280.98 K   0.00% 0.10%
CITIGROUP INC 05/12/2025 186.65 K $268.77 K   -2.85% 0.10%
PENTWATER CAPITAL MANAGEMENT LP 05/15/2025 181.29 K $261.06 K   0.00% 0.09%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2025 168.31 K $242.36 K   40.64% 0.09%
ALLIANCEBERNSTEIN L.P. 05/15/2025 159.26 K $229.33 K   0.00% 0.08%
GROUP ONE TRADING, L.P. 05/14/2025 149.72 K $215.60 K   54.14% 0.08%
SIMPLEX TRADING, LLC 05/12/2025 146.74 K $211.00 K   100.00% 0.07%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 143.54 K $206.69 K   -37.25% 0.07%

Esperion Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 260 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 14.49 M

VANGUARD GROUP INC: 11.49 M

WASATCH ADVISORS LP: 10.93 M

Bellevue Group AG: 9.69 M

Two Seas Capital LP: 6.93 M

MORGAN STANLEY: 6.59 M

57.86% of Esperion Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 136.18 M shares in the last 24 months. This purchase volume represents approximately $115.72 M in transactions.